Lemaitre Vascular (LMAT) | Financial Analysis & Statements
Lemaitre Vascular Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
64.5M
Gross Profit
46.2M
71.66%
Operating Income
18.8M
29.22%
Net Income
15.6M
24.18%
EPS (Diluted)
$0.68
Balance Sheet Metrics
Total Assets
615.7M
Total Liabilities
222.2M
Shareholders Equity
393.5M
Debt to Equity
0.56
Cash Flow Metrics
Operating Cash Flow
17.4M
Free Cash Flow
21.4M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Lemaitre Vascular Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 249.6M | 219.9M | 193.5M | 161.7M | 154.4M |
| Cost of Goods Sold | 71.1M | 69.0M | 66.4M | 56.8M | 53.0M |
| Gross Profit | 178.5M | 150.9M | 127.0M | 104.9M | 101.4M |
| Gross Margin % | 71.5% | 68.6% | 65.7% | 64.9% | 65.7% |
| Operating Expenses | |||||
| Research & Development | 14.1M | 15.6M | 17.0M | 13.3M | 11.8M |
| Selling, General & Administrative | 96.5M | 83.0M | 72.9M | 61.7M | 53.2M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 110.6M | 98.6M | 89.9M | 75.0M | 65.0M |
| Operating Income | 67.9M | 52.3M | 37.2M | 29.9M | 36.4M |
| Operating Margin % | 27.2% | 23.8% | 19.2% | 18.5% | 23.6% |
| Non-Operating Items | |||||
| Interest Income | - | 4.9M | 3.1M | 986.0K | 197.0K |
| Interest Expense | 5.2M | 205.0K | 0 | 0 | 2.2M |
| Other Non-Operating Income | 12.5M | -125.0K | -799.0K | -3.4M | -116.0K |
| Pre-tax Income | 75.2M | 56.9M | 39.5M | 27.5M | 34.3M |
| Income Tax | 17.4M | 12.8M | 9.4M | 6.9M | 7.4M |
| Effective Tax Rate % | 23.2% | 22.6% | 23.7% | 24.9% | 21.5% |
| Net Income | 57.7M | 44.0M | 30.1M | 20.6M | 26.9M |
| Net Margin % | 23.1% | 20.0% | 15.6% | 12.8% | 17.4% |
| Key Metrics | |||||
| EBITDA | 77.7M | 66.8M | 49.5M | 40.0M | 47.6M |
| EPS (Basic) | $2.55 | $1.96 | $1.36 | $0.94 | $1.27 |
| EPS (Diluted) | $2.52 | $1.93 | $1.34 | $0.93 | $1.25 |
| Basic Shares Outstanding | 22638000 | 22452000 | 22217000 | 21975000 | 21157000 |
| Diluted Shares Outstanding | 22638000 | 22452000 | 22217000 | 21975000 | 21157000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Lemaitre Vascular Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 28.2M | 25.6M | 24.3M | 19.1M | 13.9M |
| Short-term Investments | 330.9M | 274.1M | 80.8M | 63.6M | 56.1M |
| Accounts Receivable | 33.6M | 30.1M | 25.1M | 22.0M | 19.6M |
| Inventory | 58.2M | 55.9M | 52.3M | 45.3M | 40.6M |
| Other Current Assets | 5.1M | 7.5M | 6.4M | 6.7M | 4.2M |
| Total Current Assets | 468.2M | 402.2M | 194.6M | 161.7M | 139.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 41.9M | 42.0M | 39.0M | 30.9M | 31.0M |
| Goodwill | 165.0M | 167.7M | 173.6M | 178.4M | 184.6M |
| Intangible Assets | 33.1M | 35.8M | 41.7M | 46.5M | 52.7M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 5.7M | 6.3M | 4.7M | 2.7M | 2.1M |
| Total Non-Current Assets | 147.5M | 149.6M | 152.2M | 148.7M | 152.9M |
| Total Assets | 615.7M | 551.8M | 346.8M | 310.5M | 292.8M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 3.6M | 1.8M | 3.7M | 2.9M | 2.3M |
| Short-term Debt | 2.9M | 2.7M | 2.5M | 1.9M | 1.9M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 322.0K | 1.4M | 24.0K | 573.0K | 1.3M |
| Total Current Liabilities | 36.3M | 30.6M | 29.9M | 25.3M | 21.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | 182.6M | 183.0M | 16.6M | 14.7M | 14.1M |
| Deferred Tax Liabilities | 1.7M | 85.0K | 107.0K | 69.0K | 70.0K |
| Other Non-Current Liabilities | 964.0K | 259.0K | 1.6M | 1.5M | 1.9M |
| Total Non-Current Liabilities | 185.9M | 183.9M | 19.0M | 16.9M | 16.8M |
| Total Liabilities | 222.2M | 214.5M | 48.9M | 42.3M | 38.7M |
| Equity | |||||
| Common Stock | 244.0K | 242.0K | 239.0K | 237.0K | 235.0K |
| Retained Earnings | 184.7M | 145.1M | 115.4M | 97.8M | 88.1M |
| Treasury Stock | 17.4M | 15.6M | 13.9M | 13.0M | 12.4M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 393.5M | 337.3M | 297.9M | 268.2M | 254.2M |
| Key Metrics | |||||
| Total Debt | 185.6M | 185.7M | 19.1M | 16.6M | 15.9M |
| Working Capital | 431.9M | 371.6M | 164.7M | 136.4M | 118.1M |
Balance Sheet Composition
Lemaitre Vascular Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 57.7M | 44.0M | 30.1M | 20.6M | 26.9M |
| Depreciation & Amortization | 10.4M | 9.7M | 9.5M | 9.4M | 11.1M |
| Stock-Based Compensation | 7.8M | 6.6M | 5.3M | 4.2M | 3.5M |
| Working Capital Changes | -6.0M | -17.8M | -8.3M | -10.3M | -8.0M |
| Operating Cash Flow | 73.2M | 42.2M | 37.3M | 23.6M | 32.8M |
| Investing Activities | |||||
| Capital Expenditures | -6.8M | -7.0M | -7.3M | -2.4M | -4.9M |
| Acquisitions | -1.9M | 0 | -899.0K | 0 | 0 |
| Investment Purchases | -641.3M | -277.9M | -16.6M | -8.0M | -59.2M |
| Investment Sales | 585.1M | 84.8M | 0 | 0 | 3.0M |
| Investing Cash Flow | -64.9M | -200.1M | -24.7M | -10.4M | -61.1M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | -642.0K | -802.0K |
| Dividends Paid | -18.1M | -14.4M | -12.4M | -11.0M | -9.3M |
| Debt Issuance | 0 | 169.3M | - | 0 | 0 |
| Debt Repayment | - | - | 0 | 0 | -39.0M |
| Financing Cash Flow | -19.5M | 159.8M | -6.3M | -9.2M | 13.7M |
| Free Cash Flow | 74.5M | 37.2M | 29.5M | 22.1M | 30.2M |
| Net Change in Cash | -11.3M | 1.9M | 6.3M | 4.0M | -14.6M |
Cash Flow Trend
Lemaitre Vascular Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
44.80
Forward P/E
35.45
Price to Book
6.53
Price to Sales
10.33
PEG Ratio
1.18
Profitability Ratios
Profit Margin
23.13%
Operating Margin
21.77%
Return on Equity
15.80%
Return on Assets
6.76%
Financial Health
Current Ratio
12.89
Debt to Equity
47.16
Beta
0.66
Per Share Data
EPS (TTM)
$2.52
Book Value per Share
$17.28
Revenue per Share
$11.03
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| LMAT | 2.6B | 44.80 | 6.53 | 15.80% | 23.13% | 47.16 |
| Intuitive Surgical | 170.1B | 54.97 | 8.99 | 16.69% | 28.38% | 0.95 |
| Becton, Dickinson | 56.1B | 25.40 | 1.75 | 6.96% | 8.01% | 77.28 |
| Baxter International | 9.4B | 86.31 | 1.54 | -13.71% | -8.51% | 160.28 |
| AptarGroup | 8.0B | 21.10 | 2.99 | 15.10% | 10.40% | 57.10 |
| Repligen | 7.5B | 154.30 | 3.55 | 2.40% | 6.62% | 32.76 |
Financial data is updated regularly. All figures are in the company's reporting currency.






